Ricerca Biosciences agrees to buy drug discovery, development unit from MDS Pharma Services

Contract drug development organization Ricerca Biosciences LLC has agreed to acquire the discovery and preclinical business of MDS Pharma Services for $35 million less working capital and cap-ex reserve.

[Read more of this report]


Be a Thought Leader: Join MedCitizens

Anyone can blog on MedCity News when they become a "MedCitizen." MedCitizens publish their own thoughts about current medical news and the latest issues in healthcare to the entire MedCity News audience.

Click to login or learn more

MedCity Twitter Buzz

MedCity Jobs Board

Real Time Web Analytics